(427 days)
Not Found
No
The summary describes a negative pressure wound therapy dressing and system, with no mention of AI or ML capabilities in the intended use, device description, or performance studies.
Yes
The device is described as a Negative Pressure Wound Therapy (NPWT) system that promotes wound healing through the removal of wound fluids, which is a direct therapeutic benefit to the patient.
No
The device is a Negative Pressure Wound Therapy (NPWT) dressing and system intended to promote wound healing by removing fluids. It treats wounds rather than diagnosing conditions.
No
The device described is a physical wound dressing (foam) intended for use with a negative pressure wound therapy system, which is a hardware device. It is not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is a dressing used in conjunction with a Negative Pressure Wound Therapy (NPWT) system. Its purpose is to promote wound healing by removing wound fluids. This is a therapeutic application, not a diagnostic one.
- Device Description: The description reinforces that it's a wound filler for use with an NPWT system.
- Lack of Diagnostic Elements: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) to provide information about a patient's health status, disease, or condition. IVDs are designed to perform tests on these types of samples.
- Performance Studies: The performance studies described focus on wound model testing and biocompatibility, which are relevant to a therapeutic device, not an IVD.
In summary, the RENASYS White Foam NPWT Dressing is a medical device used for wound treatment, not for diagnosing a condition.
N/A
Intended Use / Indications for Use
The RENASYS White Foam NPWT Dressing is a moist, sterile, polyvinyl alcohol (PVA) foam intended to be used in conjunction with Smith & Nephew RENASYS TOUCH and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems.
The Smith & Nephew RENASYS system is indicated for patients who would benefit from a suction pump (Negative Pressure Wound Therapy) as it may promote wound healing via the removal of wound fluids, including irrigation of body fluids, wound exudates and infectious materials.
Appropriate wound types include:
- Chronic
- Acute
- Traumatic
- Sub-Acute and dehisced wounds
- Ulcers (such as pressure or diabetic)
- Partial-thickness burns
- Flaps
- Grafts
Product codes
OMP
Device Description
RENASYS™-WF White Foam NPWT Dressing for use as a wound filler in conjunction with the RENASYS Touch or GO Negative Pressure Wound Therapy System and compatible components.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Clinical and Home Environments
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
- Wound model testing in challenge conditions using compatible components
- Comparative wound model testing between the subject and predicate device
- Testing in accordance with the relevant parts of ISO 10993
No clinical study conducted or submitted as part of this submission.
Testing indicates that the subject device performs as intended and on an equivalence basis with the predicate device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4780 Powered suction pump.
(a)
Identification. A powered suction pump is a portable, AC-powered or compressed air-powered device intended to be used to remove infectious materials from wounds or fluids from a patient's airway or respiratory support system. The device may be used during surgery in the operating room or at the patient's bedside. The device may include a microbial filter.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
February 10, 2023
Smith and Nephew Medical Limited Thomas Robinson Senior Regulatory Affairs Specialist 101 Hessle Road Hull, Yorkshire HU3 2BN United Kingdom
Re: K213853
Trade/Device Name: RENASYS™-WF White Foam NPWT Dressing Small RENASYS™-WF White Foam NPWT Dressing Large Regulation Number: 21 CFR 878.4780 Regulation Name: Powered Suction Pump Regulatory Class: Class II Product Code: OMP Dated: January 11, 2023 Received: January 17, 2023
Dear Thomas Robinson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Julie A. Morabito -S
Julie Morabito, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K213853
Device Name
RENASYSTM-WF White Foam NPWT Dressing Small; RENASYS™-WF White Foam NPWT Dressing Large
Indications for Use (Describe)
The RENASYS White Foam NPWT Dressing is a moist, sterile, polyvinyl alcohol (PVA) foam intended to be used in conjunction with Smith & Nephew RENASYS TOUCH and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems.
The Smith & Nephew RENASYS system is indicated for patients who would benefit from a suction pump (Negative Pressure Wound Therapy) as it may promote wound healing via the removal of wound fluids, including irrigation of body fluids, wound exudates and infectious materials.
Appropriate wound types include:
- · Chronic
- Acute
- · Traumatic
- Sub-Acute and dehisced wounds
- · Ulcers (such as pressure or diabetic)
- · Partial-thickness burns
- · Flaps
- · Grafts
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
RENASYS™-WF White Foam NPWT Dressing Traditional 510(k) Premarket Notification
510(k) Summary
| 21 CFR 807.92 (a)(1): Submitter's Information | |
|---|---|
| 510(k) Owner Name | Smith & Nephew Medical Ltd |
| Address | 101 Hessle Road, |
| Hull, | |
| HU3 2BN, | |
| United Kingdom | |
| Establishment | |
| Registration Number | 8043484 |
| Contact Name | Thomas Robinson, Senior Regulatory Affairs Specialist |
| Telephone Number | +44 7985681790 |
| Date Prepared | February 10, 2023 |
| 21 CFR 807.92 (a)(2): Device Information | |
| Device Name | |
| (Trade/Proprietary Name) | RENASYSTM-WF White Foam NPWT Dressing Small |
| RENASYSTM-WF White Foam NPWT Dressing Large | |
| Common Name | Negative Pressure Wound Therapy Powered suction pump |
| Review Panel | General and Plastic Surgery |
| Regulation Number | Powered suction pump; 21 CFR 878.4780 |
| Regulatory Class | Class II |
| Product Code | OMP |
| 21 CFR 807.92 (a)(3): | |
| Legally marketed device to | |
| which equivalence is | |
| claimed | 510(k) Number: K133276 |
| Device Name: V.A.C.® Negative Pressure Wound Therapy System, | |
| including the V.A.C.® WHITEFOAM™ Dressing Kits | |
| 21 CFR 807.92 (a)(4): Device Description |
RENASYS™-WF White Foam NPWT Dressing for use as a wound filler in conjunction with the RENASYS Touch or GO Negative Pressure Wound Therapy System and compatible components.
4
RENASYS™-WF White Foam NPWT Dressing Traditional 510(k) Premarket Notification
21 CFR 807.92 (a)(5): Indications For Use
The RENASYS™-WF White Foam NPWT Dressing is a moist, sterile, polyvinyl alcohol (PVA) foam intended to be used in conjunction with Smith & Nephew RENASYS TOUCH and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems.
The Smith & Nephew RENASYS NPWT System is indicated for patients who would benefit from a suction pump (Negative Pressure Wound Therapy) as it may promote wound healing via the removal of fluids including irrigation and body fluids, wound exudate and infectious materials.
Appropriate wound types include:
- Chronic
- Acute
- Traumatic
- Sub-Acute and dehisced wounds
- · Ulcers (such as pressure or diabetic)
- Partial-thickness burns
- · Flaps
- Grafts
21 CFR 807.92 (a)(6): Comparison of Technological Characteristics between the Subject and Predicate Devices
The subject device and predicate device have the same physical composition; they are both made of foam material Polyvinyl Alcohol (PVA), moistened with water, sterilised by gamma irradiation and share the same dimensions (cm):
- 7.5 X 10 X 1 ●
- 15 X 10 X 1
5
RENASYS™-WF White Foam NPWT Dressing Traditional 510(k) Premarket Notification
Comparison of the Intended Uses, Indications for use, Wound Types, Contraindications, Kit Components, Materials and Packaging of the Subject and Predicate Devices
| Characteristic(s) | Subject Device: | Predicate Device: | Comparison Verdict - Substantially
Equivalent |
|-------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | RENASYSTM-WF White Foam NPWT Dressing | V.A.C Whitefoam Dressing | |
| Intended Use | The RENASYS White Foam NPWT
Dressing is a moist, sterile, polyvinyl alcohol
(PVA) foam intended to be used in
conjunction with Smith & Nephew
RENASYS TOUCH and RENASYS GO
Negative Pressure Wound Therapy (NPWT)
Systems.
The Smith & Nephew RENASYS system is
indicated for patients who would benefit
from a suction device (negative pressure
wound therapy) as it may promote wound
healing via the removal of fluids, including
irrigation and body fluids, wound exudates
and infectious materials. | The ActiV.A.C., InfoVAC., V.A.C. ATS,
V.A.C. Freedom, V.A.C. Via, and V.A.C.
Simplicity Negative Pressure Wound Therapy
Systems are integrated wound management
systems for use in acute, extended and home
care settings.
When used on open wounds, they are Intended
to create an environment that - promotes
wound healing by secondary or tertiary
(delayed primary) intention by preparing the
wound bed for closure, reducing edema,
promoting granulation tissue formation and
perfusion, and by removing exudate and
infectious material.
When used on closed surgical incisions, they
are also intended to manage the environment of
surgical incisions that continue to drain
following sutured or -stapled closure by
maintaining a closed environment and
removing exudates via the application of
negative pressure wound therapy | Yes - The subject device contains the
same indications as the predicate
device for open wounds.
Closed wounds are not listed
indications for the subject device.
These have different compatible
NPWT systems (manufacturer
specific). |
| Indications of Use
(Indicated
Wound Type) | Appropriate wound types include: chronic,
acute, traumatic, sub-acute and dehisced
wounds, ulcers (such as pressure or diabetic),
partial-thickness burns, flaps and grafts. | Open wound types include chronic, acute,
traumatic, *subacute and dehisced wounds,
partial-thickness burns, ulcers (such as
diabetic, pressure or venous Insufficiency),
flaps and grafts. . | Yes - The Indicated wound types for
the subject device are the same as the
predicate device except for the
predicate device specifically stating
Venous insufficiency ulcers, this is not
included for the subject device to keep
alignment with the compatible
RENASYS devices |
| Contraindications | The use of NPWT and the RENASYS Soft
Port is contraindicated in the presence of:
• Untreated osteomyelitis
• Exposed arteries, veins, organs or
nerves
• Necrotic tissue with eschar present
• Malignancy in wound (with exception
of palliative are to enhance quality of
life)
• Non-enteric and unexplored fistulas
• Exposed Anastomotic sites | • Do not place foam dressings of the
V.A.C. Therapy System directly in
contact with exposed blood vessels,
anastomotic sites, organs or nerves
NOTE: Refer to Warnings section for
additional information concerning Bleeding.
• V.A.C. Therapy is contraindicated for
patients with:
• Malignancy in the wound
• Untreated osteomyelitis
NOTE: Refer to Warnings section for
Osteomyelitis information.
• Non-enteric and unexplored fistulas
• Necrotic tissue with eschar present
NOTE: After debridement of necrotic tissue
and complete removal of eschar, V.A.C.
Therapy may be used | Yes - The subject device contains the
same contraindications as the
predicate device for open wounds |
| Sterility | Sterilised by Gamma Irradiation | Sterilised by Gamma Irradiation | Yes, same |
| Packaging | Polyethylene inner and Aluminum foil outer
pouch | Polyethylene inner and Aluminum foil outer
pouch | Yes, same |
| Materials | PVA Foam, moistened with water | PVA Foam, moistened with water | Yes, same |
| Status | Rx Only | Rx Only | Yes - both the subject device and
predicate device are prescription only |
| Environment of Use | Clinical and Home Environments | Clinical and Home Environments | Yes - both the subject device and
predicate device are available for use
in clinical and home environments, in
line with the respective NPWT system |
6
RENASYS™-WF White Foam NPWT Dressing
Traditional 510(k) Premarket Notification
7
RENASYS™-WF White Foam NPWT Dressing
Traditional 510(k) Premarket Notification
8
RENASYS™-WF White Foam NPWT Dressing Traditional 510(k) Premarket Notification
21 CFR 807.92 (b)(1): Brief discussion of nonclinical tests submitted/referenced/ relied on in this submission to determine substantial equivalence
- Wound model testing in challenge conditions using compatible components
- Comparative wound model testing between the subject and predicate device
- Testing in accordance with the relevant parts of ISO 10993 ●
21 CFR 807.92 (b)(2): Brief discussion of clinical tests submitted/referenced/ relied on in this submission to determine substantial equivalence
No clinical study conducted or submitted as part of this submission.
21 CFR 807.92 (b)(3): Conclusions drawn
Testing indicates that the subject device performs as intended and on an equivalence basis with the predicate device.
The subject device is substantially equivalent to the predicate device with respect to safety and effectiveness.